癌变·畸变·突变
癌變·畸變·突變
암변·기변·돌변
CARCINOGENSES,TERATOGENSIS AND MUTAGENESIS
2014年
5期
348-352
,共5页
曹迎亚%车轶群%陈群%马文韬%刘洋%郝佳洁%蔡岩%鲁卫华%王明荣%张钰%ZHANG Yu
曹迎亞%車軼群%陳群%馬文韜%劉洋%郝佳潔%蔡巖%魯衛華%王明榮%張鈺%ZHANG Yu
조영아%차질군%진군%마문도%류양%학가길%채암%로위화%왕명영%장옥%ZHANG Yu
PLK1%shRNA%诱导表达%慢病毒载体%食管癌
PLK1%shRNA%誘導錶達%慢病毒載體%食管癌
PLK1%shRNA%유도표체%만병독재체%식관암
PLK1%shRNA%inducible expression%lentivirus expression vector%esophageal cancer
目的:建立可条件性诱导PLK1-shRNA稳定表达的食管癌细胞株,为深入研究PLK1在食管癌发生发展中的作用及分子机制提供细胞模型。方法:合成PLK1-shRNA寡核苷酸,退火后连接到慢病毒表达载体pLKO-Tet-On并转化至感受态细胞Stbl3,利用菌落PCR和测序分析鉴定阳性重组子。用pLKO-shPLK1-Tet-On重组质粒和包装质粒共转染293T细胞,收集病毒上清,感染食管癌细胞KYSE510,利用嘌呤霉素筛选可诱导PLK1-shRNA稳定表达的细胞株。采用qRT-PCR和Western blot检测强力霉素(Dox)诱导PLK1-shRNA表达的效率。结果:菌落PCR和测序分析结果显示,pLKO-shPLK1-Tet-On重组质粒中PLK1-shRNA的序列及插入位点正确。包装、收获病毒并感染KYSE510细胞后,筛选获得了具有嘌呤霉素抗性的稳定细胞株KYSE510-shPLK1-Tet-On。qRT-PCR和Western blot的检测结果显示,0.1μg/mL Dox即可显著下调KYSE510-shPLK1-Tet-On细胞中PLK1的表达。结论:成功构建了诱导型PLK1-shRNA慢病毒表达载体,并筛选获得了可条件性诱导PLK1稳定敲降的食管癌细胞株,为进一步探讨PLK1异常表达与食管癌发生发展的关系提供了理想的细胞模型。
目的:建立可條件性誘導PLK1-shRNA穩定錶達的食管癌細胞株,為深入研究PLK1在食管癌髮生髮展中的作用及分子機製提供細胞模型。方法:閤成PLK1-shRNA寡覈苷痠,退火後連接到慢病毒錶達載體pLKO-Tet-On併轉化至感受態細胞Stbl3,利用菌落PCR和測序分析鑒定暘性重組子。用pLKO-shPLK1-Tet-On重組質粒和包裝質粒共轉染293T細胞,收集病毒上清,感染食管癌細胞KYSE510,利用嘌呤黴素篩選可誘導PLK1-shRNA穩定錶達的細胞株。採用qRT-PCR和Western blot檢測彊力黴素(Dox)誘導PLK1-shRNA錶達的效率。結果:菌落PCR和測序分析結果顯示,pLKO-shPLK1-Tet-On重組質粒中PLK1-shRNA的序列及插入位點正確。包裝、收穫病毒併感染KYSE510細胞後,篩選穫得瞭具有嘌呤黴素抗性的穩定細胞株KYSE510-shPLK1-Tet-On。qRT-PCR和Western blot的檢測結果顯示,0.1μg/mL Dox即可顯著下調KYSE510-shPLK1-Tet-On細胞中PLK1的錶達。結論:成功構建瞭誘導型PLK1-shRNA慢病毒錶達載體,併篩選穫得瞭可條件性誘導PLK1穩定敲降的食管癌細胞株,為進一步探討PLK1異常錶達與食管癌髮生髮展的關繫提供瞭理想的細胞模型。
목적:건립가조건성유도PLK1-shRNA은정표체적식관암세포주,위심입연구PLK1재식관암발생발전중적작용급분자궤제제공세포모형。방법:합성PLK1-shRNA과핵감산,퇴화후련접도만병독표체재체pLKO-Tet-On병전화지감수태세포Stbl3,이용균락PCR화측서분석감정양성중조자。용pLKO-shPLK1-Tet-On중조질립화포장질립공전염293T세포,수집병독상청,감염식관암세포KYSE510,이용표령매소사선가유도PLK1-shRNA은정표체적세포주。채용qRT-PCR화Western blot검측강력매소(Dox)유도PLK1-shRNA표체적효솔。결과:균락PCR화측서분석결과현시,pLKO-shPLK1-Tet-On중조질립중PLK1-shRNA적서렬급삽입위점정학。포장、수획병독병감염KYSE510세포후,사선획득료구유표령매소항성적은정세포주KYSE510-shPLK1-Tet-On。qRT-PCR화Western blot적검측결과현시,0.1μg/mL Dox즉가현저하조KYSE510-shPLK1-Tet-On세포중PLK1적표체。결론:성공구건료유도형PLK1-shRNA만병독표체재체,병사선획득료가조건성유도PLK1은정고강적식관암세포주,위진일보탐토PLK1이상표체여식관암발생발전적관계제공료이상적세포모형。
OBJECTIVE: The aim of the study was to establish a suitable cell model for investigating the role and mechanism of PLK1 overexpression in esophageal cancer through inactivation of PLK1 expression employing lentiviral-mediated inducible shRNA expression system.METHODS:Chemically synthesized PLK1-shRNA oligonucleotides were annealed and ligated into the lentiviral vector pLKO-Tet-On. The ligation products were transformed into the competentE. coli Stbl3 cells. Colony PCR and sequencing analysis were used to identify the positive recombinants. The pLKO-shPLK1-Tet-On construct and packaging plasmids were co-transfected into 293T cells to produce the lentiviral particles. Esophageal cancer cells KYSE510 were infected with the viral supernatant and the stable cell strain was selected with puromycin. Doxcyclin-induced expression efficiency of PLK1-shRNA was determined by qRT-PCR and Western blotting. RESULTS:Colony PCR and sequencing analysis showed that PLK1-shRNA oligos were correctly inserted into the pLKO-Tet-On vector. The stable cell strain KYSE510-shPLK1-Tet-On was obtained through infecting the lentivirus expressing inducible PLK1-shRNA and then selected with puromycin. The results of qRT-PCR and Western blotting indicated that the expression of PLK1 in KYSE510-shPLK1-Tet-On cells could be markedly downregulated by 0.1μg/mL Dox.CONCLUSION:We successfully constructed a lentivirus-based inducible PLK1-shRNA expression vector and established an esophageal cancer cell line with stable expression of inducible PLK1-shRNA,providing an ideal cell model for further exploring the relationship between aberrant PLK1 expression and development and progression of esophageal cancer.